284 related articles for article (PubMed ID: 21543548)
21. The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
Wynn WP; Stroman RT; Almgren MM; Clark KJ
J Pharm Pract; 2012 Dec; 25(6):591-9. PubMed ID: 23222855
[TBL] [Abstract][Full Text] [Related]
22. Association of deferring a quit attempt with smoking cessation success: a secondary analysis.
Hughes JR; Russ C; Messig MA
J Subst Abuse Treat; 2014 Feb; 46(2):264-7. PubMed ID: 24074849
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.
Kotz D; Brown J; West R
Psychopharmacology (Berl); 2014 Jan; 231(1):37-42. PubMed ID: 23873417
[TBL] [Abstract][Full Text] [Related]
24. Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey.
Fix BV; Hyland A; Rivard C; McNeill A; Fong GT; Borland R; Hammond D; Cummings KM
Int J Environ Res Public Health; 2011 Jan; 8(1):222-33. PubMed ID: 21318025
[TBL] [Abstract][Full Text] [Related]
25. Combination treatment with varenicline and nicotine replacement therapy.
Ebbert JO; Burke MV; Hays JT; Hurt RD
Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
[TBL] [Abstract][Full Text] [Related]
26. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
[TBL] [Abstract][Full Text] [Related]
27. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
Park PW; Casiano EM; Escoto L; Claveria AM
Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of varenicline for smoking cessation at 2 urban academic health centers.
Dhelaria RK; Friderici J; Wu K; Gupta E; Khan C; Rothberg MB
Eur J Intern Med; 2012 Jul; 23(5):461-4. PubMed ID: 22726377
[TBL] [Abstract][Full Text] [Related]
29. [Medical therapy for smoking cessation].
Zeller A
Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Wu P; Wilson K; Dimoulas P; Mills EJ
BMC Public Health; 2006 Dec; 6():300. PubMed ID: 17156479
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
Brose LS; West R; Stapleton JA
Mayo Clin Proc; 2013 Mar; 88(3):226-33. PubMed ID: 23489449
[TBL] [Abstract][Full Text] [Related]
32. Promoting smoking cessation.
Larzelere MM; Williams DE
Am Fam Physician; 2012 Mar; 85(6):591-8. PubMed ID: 22534270
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
[TBL] [Abstract][Full Text] [Related]
34. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
35. Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
Mariano ME; Elia D; Scarascia A; Tzani P; Giucastro G; Olivieri D; Marangio E
Acta Biomed; 2009 Apr; 80(1):42-6. PubMed ID: 19705619
[TBL] [Abstract][Full Text] [Related]
36. [On oral medications, especially varenicline].
Kurioka N
Nihon Rinsho; 2013 Mar; 71(3):487-92. PubMed ID: 23631241
[TBL] [Abstract][Full Text] [Related]
37. [Current and future medical drugs for smoking cessation].
Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice.
Wang C; Cho B; Xiao D; Wajsbrot D; Park PW
Int J Clin Pract; 2013 May; 67(5):469-76. PubMed ID: 23574106
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
[TBL] [Abstract][Full Text] [Related]
40. Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
Poulsen PB; Spillemose H; Nielsen G; Hergel LL; Wedell-Wedellsborg D; Strand M; Ringbæk T
Respir Med; 2015 Feb; 109(2):218-27. PubMed ID: 25592244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
